Physician profile
Kaith K Almefty
NPI 1750518627
$10,540.33
in general payments reported to CMS, 2019-2025
6 companies · $94.91 in 2025
The $94.91 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,243 · 2021: $1,772 · 2022: $1,100 · 2023: $67.16 · 2024: $6,263 · 2025: $94.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,640 · Travel and Lodging: $1,551 · Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,640.00 |
| Travel and Lodging | $1,551.30 |
| Food and Beverage | $233.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,188.05 | 2021-2024 | O-Arm, Midas Rex, Catalyft Pl Expandable Interbody System |
| Medtronic USA, INC. | $1,160.00 | 2020 | |
| Stryker Corporation | $94.91 | 2025 | Core |
| Aesculap, INC. | $64.17 | 2020 | |
| Misonix INC | $19.24 | 2020 | |
| Abbott Laboratories | $13.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaith Almefty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.